Auckland DHB clinical researchers awarded $2.7m

Auckland DHB clinical researchers awarded $2.7m

Researchers at the Auckland DHB have received $2.7 million of funding this week in the latest Health Research Council funding round for a range of groundbreaking projects.

These are:

• A pioneering investigation into the causes of the most severe form of epilepsy Status Epilepticus in the greater Auckland region led by neurologist r Peter Bergin ($671,183)

• The New Zealand contribution to the largest international trial of sedation in critically ill patients that will determine the better of two current sedative options for patients on ventilators led by critical care specialist Dr Colin McArthur

($1,118,621)

• A trial to determine the optimum level of intravenous fluid with potential impacts on the 250 million people a year worldwide who undergo major surgery led by cardiovascular intensive care specialist Dr Shay McGuinness study ($770,668)

Auckland DHB Chief Executive Ailsa Claire said the grants showed the value the country’s research community placed on the work of clinical research teams at Auckland City Hospital and the Greenlane Clinical Centre.

“These clinicians are on the frontline of delivering excellence in health care. Their research is firmly focused on how to do better for our patients. They deserve warm congratulations.”

She said that Auckland City Hospital clinicians had a 100 per cent success rate with their full applications in this round, which showed recognition of the potential global impact and value of the research.

In addition to the three successful major project grants, Auckland City hospital clinicians were successful with applications for funding for two feasibility studies that are the interim stage for major research projects.

Dr Shay McGuinness will lead a study of how the control of oxygen levels during
heart bypass surgery can improve patient outcomes. ($141,411)

ENDS

© Scoop Media